Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2021-12-03

Clinical Trial Update: Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema [Phase 4]

View source ↗

Summary

Phase 4 trial update examining bevacizumab and peripheral retinal changes on wide-field angiography in diabetic retinopathy and diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (bevacizumab)

Snippet

Sponsor: King Khaled Eye Specialist Hospital | Conditions: Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy | Phase 4 | Status: COMPLETED